Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background and Objective</h3>: Association rule mining has been adopted to medical fields to discover prescribing patterns or relationships among diseases and/or medications; however, it has generated unreasonable associations among these entities. This study aims to identify the real-world profile of disease-medication (DM) associations using the modified mining algorithm and assess its performance in reducing DM pseudo-associations.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3>: We retrieved data from outpatient records between January 2011 and December 2015 in claims databases maintained by the Health and Welfare Data Science Center, Ministry of Health and Welfare, Taiwan. The association rule mining's lift (Q-value) was adopted to quantify DM associations, referred to as Q1 for the original algorithm and as Q2 for the modified algorithm. One thousand DM pairs with positive Q1-values (<math>Q1+</math>) and negative or no Q2-values (<math>Q2−</math> or <math>Q2∅</math>) were selected as the validation dataset, in which two pharmacists assessed the DM associations.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3>: A total of 3,120,449 unique DM pairs were identified, of which there were 333,347 <math>Q1+Q2−</math> pairs and 429,931 <math>Q1+Q2∅</math> pairs. <math>Q1+Q2−</math> rates were relatively high in ATC classes C (29.91%) and R (30.24%). Classes L (69.91%) and V (52.52%) demonstrated remarkably high <math>Q1+Q2∅</math> rates. For the 1000 pairs in the validation, 93.7% of the <math>Q1+Q2−</math> or <math>Q1+Q2∅</math> DM pairs were assessed as pseudo-associations. However, classes M (5.3%), H (4.5%), and B (4.1%) showed the highest rates of plausible associations falsely given <math>Q2−</math> or <math>Q2∅</math> by the modified algorithm.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3>: The modified algorithm demonstrated high accuracy to identify pseudo-associations regarded as positive associations by the original algorithm and would potentially be applied to improve secondary databases to facilitate research on real-world prescribing patterns and further enhance drug safety.

Refining Adverse Drug Reactions using Association Rule Mining for Electronic Healthcare Data

Application of Association Rules Analysis in Mining Adverse Drug Reaction Signals

Refining adverse drug reaction signals by incorporating interaction variables identified using emergent pattern mining

Graphic Mining of High-Order Drug Interactions and Their Directional Effects on Myopathy Using Electronic Medical Records

Exploration of the Association Rules Mining Technique for the Signal Detection of Adverse Drug Events in Spontaneous Reporting Systems

Exploring the associations between drug side-effects and therapeutic indications.

Detecting Potential Adverse Drug Reactions Using Association Rules and Embedding Models.

Association Rules in the Surveillance of Adverse Drug Reaction Signals Detection

System and Empirical Study on Adverse Drug Reaction Warning Based on Association Rule

Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study

A method for systematic discovery of adverse drug events from clinical notes.

Dydruma : A Dynamic Drug Map for Exploring the Associations Among Drug Therapeutic Indications and Side-Effects

Improved diagnosis-medication association mining to reduce pseudo-associations

Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports

Detecting Adverse Drug Event Signals from a Clinical CaseBase.

Signalling Paediatric Side Effects using an Ensemble of Simple Study Designs

A Supervised Adverse Drug Reaction Signalling Framework Imitating Bradford Hill's Causality Considerations

Exploring the predictive factors of heart disease using rare association rule mining

Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data

A Novel Semi-Supervised Algorithm for Rare Prescription Side Effect Discovery

A Study of Complication Identification Based on Weighted Association Rule Mining.